Renae Walsh
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 18
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 7
- Hepatology 12
- Hepatitis C virus research 12
- Co-authors
- Stephen Locarnini (13 shared papers)Peter Revill (6 shared papers)Lilly Yuen (5 shared papers)Danni Colledge (4 shared papers)Hans Netter (6 shared papers)George O. Lovrecz (4 shared papers)Elsdon Storey (3 shared papers)Nadia Warner (4 shared papers)
- Journals
- Journal of Hepatology (5 papers)Journal of Virology (3 papers)Virology (2 papers)Journal of Medical Virology (2 papers)Vaccine (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Renae Walsh
21 papers receiving 377 citations
Peers
Comparison fields: 5 of 44
- Hepatology 156
- Epidemiology 241
- Virology 14
- Immunology 54
- Infectious Diseases 45
Countries citing papers authored by Renae Walsh
This map shows the geographic impact of Renae Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renae Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renae Walsh more than expected).
Fields of papers citing papers by Renae Walsh
This network shows the impact of papers produced by Renae Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renae Walsh. The network helps show where Renae Walsh may publish in the future.
Co-authors
The 25 scholars most cited alongside Renae Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 53 | |
| 2 | 2020 | 51 | |
| 3 | 2016 | 39 | |
| 4 | 2015 | 32 | |
| 5 | 2009 | 31 | |
| 6 | 2020 | 31 | |
| 7 | 2021 | 24 | |
| 8 | 2012 | 24 | |
| 9 | 2005 | 23 | |
| 10 | 2004 | 19 | |
| 11 | 2019 | 12 | |
| 12 | 2016 | 11 | |
| 13 | 2012 | 10 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 5 | |
| 16 | 2007 | 3 | |
| 17 | 2016 | 3 | |
| 18 | 2023 | 1 | |
| 19 | 2022 | 1 | |
| 20 | Inarigivir: a novel RIG-I agonist for chronic hepatitis B | 2018 | 1 |
About Renae Walsh
Renae Walsh is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cellular and Molecular Neuroscience and Immunology, having authored 21 papers that have together received 382 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (7 papers), Immunotherapy and Immune Responses (3 papers), Genetic Neurodegenerative Diseases (3 papers), Ubiquitin and proteasome pathways (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Hepatology (156 citations), Epidemiology (241 citations), Virology (14 citations), Immunology (54 citations) and Infectious Diseases (45 citations). Renae Walsh has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Stephen Locarnini, Peter Revill, Lilly Yuen, Danni Colledge, Hans Netter, George O. Lovrecz, Elsdon Storey, Nadia Warner, Morten Thaysen‐Andersen and Kate Griffiths. Their work appears in journals such as Journal of Hepatology, Journal of Virology, Virology, Journal of Medical Virology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.